Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Innodata Inc (INOD) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade
Innodata IncTrade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs Innodata Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while Innodata Inc trades at $51.97 (market cap $2.01B). The key difference: Indivior Pharmaceuticals Inc. Common Stock is far larger — about 2.1× Innodata Inc's market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, Innodata Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Innodata Inc for 20 Days on average.

INDVINOD
Market Cap
$4.18B$2.01B
Volume
1,819,746722,859
Sector
HealthTechnology
52-Week High
$41.83$121.50
52-Week Low
$24.09$34.45
Typical Hold Time
0 Days20 Days
Enterprise Value
$4.47B$1.76B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Innodata Inc

INOD is trading at $58.38, down 2.55% with a bearish technical signal despite recent earnings beats. The company shows strong fundamentals with 42.71% gross margins and 37.74% ROE, while expanding into motion-capture AI labs and agentic reinforcement learning. Analyst consensus remains positive with 66.7% buy ratings, though valuation metrics appear elevated with a P/E of 45.26.

The outlook balances strong AI services growth against premium valuation concerns. Investment opportunity lies in continued execution on AI data engineering contracts with major tech companies, while risks include customer concentration and competitive pressures in the rapidly evolving AI infrastructure market.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
INOD
76% Buy24% Sell
Avg holding period · 20 Days

Top news

Latest headlines on both assets

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About Innodata Inc

Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.

Read more on INOD →